CT
WST icon

Colonial Trust’s West Pharmaceutical WST Stock Holding History

Colonial Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Hold
115
– – 0.01% 555
2026
Q1 		$28.8K Hold
115
– – ﹤0.01% 613
2025
Q4 		$31.6K Hold
115
– – ﹤0.01% 615
2025
Q3 		$30.2K Hold
115
– – ﹤0.01% 612
2025
Q2 		$25.2K Sell
115
-3
-3% -$641 ﹤0.01% 640
2025
Q1 		$26.4K Buy
118
+5
+4% +$1.38K ﹤0.01% 642
2024
Q4 		$37K Buy
113
+1
+0.9% +$315 0.01% 639
2024
Q3 		$34.8K Hold
112
– – 0.01% 610
2024
Q2 		$36.8K Hold
112
– – 0.01% 562
2024
Q1 		$44.1K Hold
112
– – 0.01% 529
2023
Q4 		$39.8K Hold
112
– – 0.01% 540
2023
Q3 		$45.2K Buy
112
+37
+49% +$14.3K 0.01% 489
2023
Q2 		$28.3K Hold
75
– – 0.01% 553
2023
Q1 		$25.6K Hold
75
– – 0.01% 550
2022
Q4 		$17.9K Buy
+75
New +$17.8K ﹤0.01% 587

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Colonial Trust's WST Position: Q2 2026 in Review

Colonial Trust held its West Pharmaceutical (WST) position steady in Q2 2026 at 115 shares worth $41.3K. The position accounts for 0.01% of the portfolio, ranked #555.

Colonial Trust first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $45.2K in Q3 2023. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Colonial Trust held 115 shares of West Pharmaceutical worth $41.3K as of Q2 2026.
  • Colonial Trust left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #555 holding.
  • Colonial Trust first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's West Pharmaceutical position peaked at $45.2K in Q3 2023.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.